BioInvent to Produce CAN10, Cantargia’s Antibody for Scleroderma, Under New Deal
News
Cantargia‘s antibody CAN10, intended to treat people with scleroderma and myocarditis, will be produced by BioInvent under the terms of a new manufacturing agreement, the two companies announced. The investigational therapy is ... Read more